CERE / Cerevel Therapeutics Holdings, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Cerevel Therapeutics Holdings, Inc.
US ˙ NasdaqCM ˙ US15678U1280
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier1.535.450 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Cerevel Therapeutics Holdings, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CERE / Cerevel Therapeutics Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-10-16 PERCEPTIVE ADVISORS LLC 876.808 22,8100 876.808 22,8100 19.999.990 289 44.9600 19.421.298 97,11
2023-10-16 BAIN CAPITAL INVESTORS LLC 5.480.052 22,8100 5.480.052 22,8100 124.999.986
2023-08-04 Burgess Paul D. 21.880 22,9339 21.880 22,9339 501.794
2023-08-03 Renaud Ronald C JR 83.857 23,9552 83.857 23,9552 2.008.811
2022-08-16 PERCEPTIVE ADVISORS LLC 1.425.000 35,0000 1.425.000 35,0000 49.875.000
2021-08-26 PERCEPTIVE ADVISORS LLC 68.047 30,2300 68.047 30,2300 2.057.061
2021-08-25 PERCEPTIVE ADVISORS LLC 61.387 28,5700 61.387 28,5700 1.753.827
2021-08-24 PERCEPTIVE ADVISORS LLC 69.761 27,7300 69.761 27,7300 1.934.473
2021-08-23 PERCEPTIVE ADVISORS LLC 44.437 25,7800 44.437 25,7800 1.145.586

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CERE / Cerevel Therapeutics Holdings, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CERE / Cerevel Therapeutics Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-02-07 COLES N ANTHONY 2.506 41,5441 2.506 41,5441 104.110 140 38.9600 -6.475 -6,22
2024-02-07 Renger John 2.161 41,5441 2.161 41,5441 89.777
2023-12-22 DiPietro Kenneth 8.000 41,4510 8.000 41,4510 331.608
2023-12-20 Tregoning Kathleen 6.288 41,4232 6.288 41,4232 260.469
2023-12-20 ALTSCHULLER Susan 13.808 41,4232 13.808 41,4232 571.972
2023-12-20 Sanchez Ramiro 10.152 41,4232 10.152 41,4232 420.528
2023-12-20 Akamine Scott 7.072 41,4232 7.072 41,4232 292.945
2023-12-20 DiPietro Kenneth 6.256 41,4232 6.256 41,4232 259.144
2023-12-20 Bodenrader Mark 7.889 41,4232 7.889 41,4232 326.788

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CERE / Cerevel Therapeutics Holdings, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-08-05 2024-08-01 4 PFIZER INC CERE Common Stock U - Other D 45,0000 -27.349.211 -1.230.714 0
2024-08-05 2024-08-01 4 BAIN CAPITAL INVESTORS LLC See footnotes CERE Common Stock D - Sale to Issuer I -65.679.781 0
2024-08-05 2024-08-01 4 Gordon Christopher R See footnotes CERE Common Stock D - Sale to Issuer I -65.679.781 0
2024-08-05 2024-08-01 4 Gordon Christopher R CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 Gordon Christopher R CERE Common Stock D - Sale to Issuer D -3.282 10.461
2024-08-05 2024-08-01 4 Koppel Adam See footnotes CERE Common Stock D - Sale to Issuer I -65.679.781 0
2024-08-05 2024-08-01 4 Koppel Adam CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 Koppel Adam CERE Common Stock D - Sale to Issuer D -3.282 10.461
2024-08-05 2024-08-01 4 Sanchez Ramiro CERE Common Stock D - Sale to Issuer D -14.673 0
2024-08-05 2024-08-01 4 Renaud Ronald C JR By Trust CERE Common Stock D - Sale to Issuer I -83.857 0
2024-08-05 2024-08-01 4 Renaud Ronald C JR CERE Common Stock D - Sale to Issuer D -160.452 0
2024-08-05 2024-08-01 4 Giordano Douglas E. CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 Giordano Douglas E. CERE Common Stock D - Sale to Issuer D -3.282 10.461
2024-08-05 2024-08-01 4 Akamine Scott CERE Common Stock D - Sale to Issuer D -7.527 0
2024-08-05 2024-08-01 4 Mckernan Ruth CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 Mckernan Ruth CERE Common Stock D - Sale to Issuer D -3.282 10.461
2024-08-05 2024-08-01 4 Greene-Sulzberger Gabrielle CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 Greene-Sulzberger Gabrielle CERE Common Stock D - Sale to Issuer D -48.415 10.461
2024-08-05 2024-08-01 4 DiPietro Kenneth CERE Common Stock D - Sale to Issuer D -25.042 0
2024-08-05 2024-08-01 4 Renger John CERE Common Stock D - Sale to Issuer D -6.370 0
2024-08-05 2024-08-01 4 Tregoning Kathleen CERE Common Stock D - Sale to Issuer D -10.666 0
2024-08-05 2024-08-01 4 DEKKERS MARIJN E CERE Common Stock D - Sale to Issuer I -402.326 0
2024-08-05 2024-08-01 4 DEKKERS MARIJN E CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 DEKKERS MARIJN E CERE Common Stock D - Sale to Issuer D -31.822 10.461
2024-08-05 2024-08-01 4 ALTSCHULLER Susan CERE Common Stock D - Sale to Issuer D -16.913 0
2024-08-05 2024-08-01 4 RIEDEL NORBERT G CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 RIEDEL NORBERT G CERE Common Stock D - Sale to Issuer D -46.092 10.461
2024-08-05 2024-08-01 4 Bodenrader Mark CERE Common Stock D - Sale to Issuer D -17.724 0
2024-08-05 2024-08-01 4 PATRICK DEVAL L CERE Common Stock D - Sale to Issuer D -10.461 0
2024-08-05 2024-08-01 4 PATRICK DEVAL L CERE Common Stock D - Sale to Issuer D -3.282 10.461
2024-08-05 2024-08-01 4 COLES N ANTHONY CERE Common Stock D - Sale to Issuer D -10.290 0
2024-08-05 2024-08-01 4 COLES N ANTHONY CERE Common Stock D - Sale to Issuer D -15.638 10.290
2024-08-05 2024-08-01 4 Burgess Paul D. CERE Common Stock D - Sale to Issuer D -45.727 0
2024-07-03 2024-07-01 4 COLES N ANTHONY CERE Common Stock S - Sale D 41,1814 -25.000 -1.030 25.928
2024-07-03 2024-07-01 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 25.000 88 50.928
2024-06-07 2024-06-05 4 Gordon Christopher R CERE Common Stock A - Award D 10.461 13.743
2024-06-07 2024-06-05 4 Koppel Adam CERE Common Stock A - Award D 10.461 13.743
2024-06-07 2024-06-05 4 PATRICK DEVAL L CERE Common Stock A - Award D 10.461 13.743
2024-06-07 2024-06-05 4 DEKKERS MARIJN E CERE Common Stock A - Award D 10.461 42.283
2024-06-07 2024-06-05 4 COLES N ANTHONY CERE Common Stock A - Award D 10.290 25.928
2024-06-07 2024-06-05 4 Giordano Douglas E. CERE Common Stock A - Award D 10.461 13.743
2024-06-07 2024-06-05 4 RIEDEL NORBERT G CERE Common Stock A - Award D 10.461 56.553
2024-06-07 2024-06-05 4 Mckernan Ruth CERE Common Stock A - Award D 10.461 13.743
2024-06-07 2024-06-05 4 Greene-Sulzberger Gabrielle CERE Common Stock A - Award D 10.461 58.876
2024-06-05 2024-06-03 4 COLES N ANTHONY CERE Common Stock S - Sale D 40,6104 -50.000 -2.031 15.638
2024-06-05 2024-06-03 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 65.638
2024-05-14 2024-05-10 4 COLES N ANTHONY CERE Common Stock S - Sale D 42,1025 -50.000 -2.105 15.638
2024-05-14 2024-05-10 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 65.638
2024-04-03 2024-04-01 4 COLES N ANTHONY CERE Common Stock S - Sale D 42,3328 -50.000 -2.117 15.638
2024-04-03 2024-04-01 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 65.638
2024-03-06 2024-03-04 4 COLES N ANTHONY CERE Common Stock S - Sale D 41,0110 -50.000 -2.051 15.638
2024-03-06 2024-03-04 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 65.638
2024-03-04 2024-02-29 4 COLES N ANTHONY CERE Common Stock S - Sale D 41,1578 -50.000 -2.058 15.638
2024-03-04 2024-02-29 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 65.638
2024-02-21 2024-02-20 4 PERCEPTIVE ADVISORS LLC CERE Common Stock G - Gift I -170.317 0
2024-02-13 2023-08-29 5 Greene-Sulzberger Gabrielle CERE Common Stock G - Gift D 562 48.415
2024-02-08 2024-02-07 4 Renger John CERE Common Stock S - Sale D 41,5441 -2.161 -90 6.370
2024-02-08 2024-02-06 4 Renger John CERE Common Stock M - Exercise D 5.020 8.531
2024-02-08 2024-02-07 4 COLES N ANTHONY CERE Common Stock S - Sale D 41,5441 -2.506 -104 15.638
2024-02-08 2024-02-06 4 COLES N ANTHONY CERE Common Stock M - Exercise D 15.440 18.144
2024-01-04 2024-01-02 4 COLES N ANTHONY CERE Common Stock S - Sale D 42,2363 -50.000 -2.112 2.704
2024-01-04 2024-01-02 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2023-12-28 2023-12-26 4 Sanchez Ramiro CERE Common Stock S - Sale D 42,4700 -10.000 -425 14.673
2023-12-28 2023-12-26 4 Sanchez Ramiro CERE Common Stock M - Exercise D 3,5000 10.000 35 24.673
2023-12-28 2023-12-26 4 Tregoning Kathleen CERE Common Stock M - Exercise D 10,0500 3.150 32 10.666
2023-12-27 2023-12-22 4 DiPietro Kenneth CERE Common Stock S - Sale D 41,4510 -8.000 -332 24.663
2023-12-27 2023-12-22 4 DiPietro Kenneth CERE Common Stock M - Exercise D 3,5000 8.000 28 32.663
2023-12-21 2023-12-20 4 Bodenrader Mark CERE Common Stock S - Sale D 41,4232 -7.889 -327 17.724
2023-12-21 2023-12-19 4 Bodenrader Mark CERE Common Stock M - Exercise D 5.085 25.613
2023-12-21 2023-12-19 4 Bodenrader Mark CERE Common Stock M - Exercise D 14.199 20.528
2023-12-21 2023-12-19 4 Burgess Paul D. CERE Common Stock M - Exercise D 23.847 45.727
2023-12-21 2023-12-20 4 DiPietro Kenneth CERE Common Stock S - Sale D 41,4232 -6.256 -259 24.663
2023-12-21 2023-12-19 4 DiPietro Kenneth CERE Common Stock M - Exercise D 13.913 30.919
2023-12-21 2023-12-20 4 Akamine Scott CERE Common Stock S - Sale D 41,4232 -7.072 -293 7.237
2023-12-21 2023-12-19 4 Akamine Scott CERE Common Stock M - Exercise D 13.796 14.309
2023-12-21 2023-12-19 4 Renaud Ronald C JR CERE Common Stock M - Exercise D 160.452 160.452
2023-12-21 2023-12-20 4 Sanchez Ramiro CERE Common Stock S - Sale D 41,4232 -10.152 -421 14.673
2023-12-21 2023-12-19 4 Sanchez Ramiro CERE Common Stock M - Exercise D 24.825 24.825
2023-12-21 2023-12-20 4 ALTSCHULLER Susan CERE Common Stock S - Sale D 41,4232 -13.808 -572 16.913
2023-12-21 2023-12-19 4 ALTSCHULLER Susan CERE Common Stock M - Exercise D 30.721 30.721
2023-12-21 2023-12-20 4 Tregoning Kathleen CERE Common Stock S - Sale D 41,4232 -6.288 -260 7.516
2023-12-21 2023-12-19 4 Tregoning Kathleen CERE Common Stock M - Exercise D 13.804 13.804
2023-12-19 2023-12-15 4 Sanchez Ramiro CERE Common Stock S - Sale D 41,3857 -7.500 -310 0
2023-12-19 2023-12-15 4 Sanchez Ramiro CERE Common Stock M - Exercise D 9,8800 7.500 74 7.500
2023-12-11 2023-12-07 4 Sanchez Ramiro CERE Common Stock S - Sale D 41,3700 -10.000 -414 0
2023-12-11 2023-12-07 4 Sanchez Ramiro CERE Common Stock M - Exercise D 3,5000 10.000 35 10.000
2023-12-07 2023-12-07 4 Akamine Scott CERE Common Stock S - Sale D 41,3700 -10.000 -414 513
2023-12-07 2023-12-07 4 Akamine Scott CERE Common Stock M - Exercise D 13,1700 10.000 132 10.513
2023-12-07 2023-12-05 4 Akamine Scott CERE Common Stock S - Sale D 35,0000 -7.500 -262 513
2023-12-07 2023-12-05 4 Akamine Scott CERE Common Stock M - Exercise D 13,1700 7.500 99 8.013
2023-11-16 2023-11-14 4 COLES N ANTHONY CERE Common Stock S - Sale D 25,1251 -22.824 -573 2.704
2023-11-16 2023-11-14 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 22.824 80 25.528
2023-11-09 2023-11-08 4 COLES N ANTHONY CERE Common Stock S - Sale D 25,1600 -100 -3 2.704
2023-11-09 2023-11-08 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 100 0 2.804
2023-11-09 2023-11-07 4 COLES N ANTHONY CERE Common Stock S - Sale D 25,0242 -27.076 -678 2.704
2023-11-09 2023-11-07 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 27.076 95 29.780
2023-11-06 2023-11-03 4 COLES N ANTHONY CERE Common Stock S - Sale D 25,4305 -61.401 -1.561 2.704
2023-11-06 2023-11-03 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 61.401 215 64.105
2023-11-06 2023-11-02 4 COLES N ANTHONY CERE Common Stock S - Sale D 25,1882 -38.599 -972 2.704
2023-11-06 2023-11-02 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 38.599 135 41.303
2023-11-03 2023-11-01 4 PATRICK DEVAL L CERE Common Stock S - Sale D 25,0000 -30.130 -753 3.282
2023-11-03 2023-11-01 4 PATRICK DEVAL L CERE Common Stock M - Exercise D 12,6200 30.130 380 33.412
2023-10-18 2023-10-16 4 BAIN CAPITAL INVESTORS LLC See footnotes CERE Common Stock P - Purchase I 22,8100 5.480.052 125.000 65.679.781
2023-10-18 2023-10-16 4 Koppel Adam See footnotes CERE Common Stock P - Purchase I 22,8100 5.480.052 125.000 65.679.781
2023-10-18 2023-10-16 4 Gordon Christopher R See footnotes CERE Common Stock P - Purchase I 22,8100 5.480.052 125.000 65.679.781
2023-10-17 2023-10-16 4 PERCEPTIVE ADVISORS LLC CERE Common Stock P - Purchase I 22,8100 876.808 20.000 10.794.876
2023-09-08 2023-09-07 4 COLES N ANTHONY CERE Common Stock S - Sale D 24,0683 -50.000 -1.203 2.704
2023-09-08 2023-09-07 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2023-08-07 2023-08-04 4 Burgess Paul D. CERE Common Stock P - Purchase D 22,9339 21.880 502 21.880
2023-08-07 2023-08-03 4 Renaud Ronald C JR By Trust CERE Common Stock P - Purchase I 23,9552 83.857 2.009 83.857
2023-07-13 2023-07-11 4 COLES N ANTHONY CERE Common Stock S - Sale D 30,0268 -50.000 -1.501 2.704
2023-07-13 2023-07-11 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2023-06-20 2023-06-15 4 DEKKERS MARIJN E CERE Common Stock S - Sale I 34,4300 -200.000 -6.886 402.326
2023-06-12 2023-06-07 4 BAIN CAPITAL INVESTORS LLC See footnotes CERE Common Stock J - Other I -432.627 60.199.729
2023-06-09 2023-06-07 4 Gordon Christopher R See footnotes CERE Common Stock J - Other I -432.627 60.199.729
2023-06-09 2023-06-07 4 Gordon Christopher R CERE Common Stock A - Award D 3.282 3.282
2023-06-09 2023-06-07 4 Koppel Adam See footnotes CERE Common Stock J - Other I -432.627 60.199.729
2023-06-09 2023-06-07 4 Koppel Adam CERE Common Stock A - Award D 3.282 3.282
2023-06-09 2023-06-07 4 Greene-Sulzberger Gabrielle CERE Common Stock A - Award D 3.282 47.853
2023-06-09 2023-06-07 4 RIEDEL NORBERT G CERE Common Stock A - Award D 3.282 46.092
2023-06-09 2023-06-07 4 Mckernan Ruth CERE Common Stock A - Award D 3.282 3.282
2023-06-09 2023-06-07 4 Giordano Douglas E. CERE Common Stock A - Award D 3.282 3.282
2023-06-09 2023-06-07 4 DEKKERS MARIJN E CERE Common Stock A - Award D 3.282 31.822
2023-06-09 2023-06-07 4 PATRICK DEVAL L CERE Common Stock A - Award D 3.282 3.282
2023-06-05 2023-06-01 4 COLES N ANTHONY CERE Common Stock S - Sale D 32,6014 -50.000 -1.630 2.704
2023-06-05 2023-06-01 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2023-06-05 2023-06-02 4 Bodenrader Mark CERE Common Stock S - Sale D 32,9500 -1.895 -62 5.522
2023-06-05 2023-06-01 4 Bodenrader Mark CERE Common Stock M - Exercise D 4.733 7.417
2023-05-08 2023-05-04 4 COLES N ANTHONY CERE Common Stock S - Sale D 32,9300 -300 -10 2.704
2023-05-08 2023-05-04 4 COLES N ANTHONY CERE Common Stock S - Sale D 31,7579 -12.132 -385 3.004
2023-05-08 2023-05-04 4 COLES N ANTHONY CERE Common Stock S - Sale D 31,3636 -37.568 -1.178 15.136
2023-05-08 2023-05-04 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2023-04-13 2023-04-11 4 COLES N ANTHONY CERE Common Stock S - Sale D 25,0626 -50.000 -1.253 2.704
2023-04-13 2023-04-11 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2023-03-06 2023-03-03 4 COLES N ANTHONY CERE Common Stock S - Sale D 27,1900 -3.000 -82 2.704
2023-03-06 2023-03-03 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 3.000 10 5.704
2023-03-06 2023-03-02 4 COLES N ANTHONY CERE Common Stock S - Sale D 27,1144 -47.000 -1.274 2.704
2023-03-06 2023-03-02 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 47.000 164 49.704
2023-02-14 2022-12-21 5 DEKKERS MARIJN E CERE Common Stock G - Gift D -14.270 28.540
2023-02-14 2022-10-03 5 Greene-Sulzberger Gabrielle CERE Common Stock G - Gift D -49.624 14.270
2023-02-08 2023-02-07 4 COLES N ANTHONY CERE Common Stock S - Sale D 33,5745 -7.942 -267 2.704
2023-02-08 2023-02-07 4 COLES N ANTHONY CERE Common Stock S - Sale D 33,0437 -42.058 -1.390 10.646
2023-02-08 2023-02-07 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2023-01-06 2023-01-05 4 COLES N ANTHONY CERE Common Stock S - Sale D 30,7320 -500 -15 2.704
2023-01-06 2023-01-05 4 COLES N ANTHONY CERE Common Stock S - Sale D 29,9294 -49.500 -1.482 3.204
2023-01-06 2023-01-05 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2022-12-13 2022-12-09 4 COLES N ANTHONY CERE Common Stock S - Sale D 27,0932 -5.145 -139 2.704
2022-12-13 2022-12-09 4 COLES N ANTHONY CERE Common Stock S - Sale D 26,6170 -44.855 -1.194 7.849
2022-12-13 2022-12-09 4 COLES N ANTHONY CERE Common Stock M - Exercise D 3,5000 50.000 175 52.704
2022-11-03 2022-11-01 4 Renger John CERE Common Stock S - Sale D 30,0002 -25.000 -750 2.704
2022-11-03 2022-11-01 4 Renger John CERE Common Stock M - Exercise D 10,2800 14.982 154 27.704
2022-11-03 2022-11-01 4 Renger John CERE Common Stock M - Exercise D 3,5000 10.018 35 12.722
2022-10-06 2022-10-04 4 Renger John CERE Common Stock S - Sale D 30,0000 -25.000 -750 2.704
2022-10-06 2022-10-04 4 Renger John CERE Common Stock M - Exercise D 10,2800 14.982 154 27.704
2022-10-06 2022-10-04 4 Renger John CERE Common Stock M - Exercise D 3,5000 10.018 35 12.722
2022-09-14 2022-09-12 4 PATRICK DEVAL L CERE Common Stock S - Sale D 30,7813 -47.705 -1.468 0
2022-09-14 2022-09-12 4 PATRICK DEVAL L CERE Common Stock M - Exercise D 12,6200 47.705 602 47.705
2022-09-12 2022-09-08 4 Ceesay Abraham CERE Common Stock S - Sale D 32,5000 -19.210 -624 0
2022-09-12 2022-09-08 4 Ceesay Abraham CERE Common Stock M - Exercise D 13,1700 19.210 253 19.210
2022-08-24 2022-08-22 4 Ceesay Abraham CERE Common Stock S - Sale D 32,5000 -9.605 -312 0
2022-08-24 2022-08-22 4 Ceesay Abraham CERE Common Stock M - Exercise D 13,1700 9.605 126 9.605
2022-08-18 2022-08-16 4 PERCEPTIVE ADVISORS LLC CERE Common Stock P - Purchase I 35,0000 1.425.000 49.875 6.511.727
2022-08-17 2022-08-15 4 Ceesay Abraham CERE Common Stock S - Sale D 34,1200 -9.606 -328 0
2022-08-17 2022-08-15 4 Ceesay Abraham CERE Common Stock M - Exercise D 13,1700 9.606 127 9.606
2022-08-12 2022-08-10 4 Renger John CERE Common Stock S - Sale D 41,0993 -18.859 -775 2.704
2022-08-12 2022-08-10 4 Renger John CERE Common Stock S - Sale D 40,1907 -36.141 -1.453 21.563
2022-08-12 2022-08-10 4 Renger John CERE Common Stock M - Exercise D 10,2800 25.376 261 57.704
2022-08-12 2022-08-10 4 Renger John CERE Common Stock M - Exercise D 3,5000 29.624 104 32.328
2022-08-09 2022-08-08 4 Akamine Scott CERE Common Stock S - Sale D 40,0001 -10.000 -400 0
2022-08-09 2022-08-08 4 Akamine Scott CERE Common Stock M - Exercise D 13,1700 10.000 132 10.000
2022-08-09 2022-08-08 4 Ceesay Abraham CERE Common Stock S - Sale D 39,5000 -9.605 -379 0
2022-08-09 2022-08-08 4 Ceesay Abraham CERE Common Stock S - Sale D 37,7500 -9.606 -363 9.605
2022-08-09 2022-08-08 4 Ceesay Abraham CERE Common Stock M - Exercise D 13,1700 19.211 253 19.211
2022-08-09 2022-08-05 4 Ceesay Abraham CERE Common Stock S - Sale D 32,5000 -38.424 -1.249 0
2022-08-09 2022-08-05 4 Ceesay Abraham CERE Common Stock M - Exercise D 13,1700 38.424 506 38.424
2022-08-09 2022-08-08 4 Renger John CERE Common Stock S - Sale D 37,7500 -10.000 -378 2.704
2022-08-09 2022-08-08 4 Renger John CERE Common Stock M - Exercise D 3,5000 10.000 35 12.704
2022-08-09 2022-08-05 4 Renger John CERE Common Stock S - Sale D 32,5000 -20.000 -650 2.704
2022-08-09 2022-08-05 4 Renger John CERE Common Stock M - Exercise D 3,5000 20.000 70 22.704
2022-07-22 2022-07-20 4 Renger John CERE Common Stock S - Sale D 30,0000 -25.000 -750 2.704
2022-07-22 2022-07-20 4 Renger John CERE Common Stock M - Exercise D 3,5000 25.000 88 27.704
2022-07-07 2022-07-06 4 Renger John CERE Common Stock S - Sale D 32,5000 -1.105 -36 2.704
2022-07-07 2022-07-06 4 Renger John CERE Common Stock M - Exercise D 3,5000 1.105 4 3.809
2022-07-07 2022-07-05 4 Renger John CERE Common Stock S - Sale D 30,0000 -25.000 -750 2.704
2022-07-07 2022-07-05 4 Renger John CERE Common Stock M - Exercise D 3,5000 25.000 88 27.704
2022-06-28 2022-06-24 4 Greene-Sulzberger Gabrielle CERE Common Stock M - Exercise D 14.270 63.894
2022-04-15 2022-04-13 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -45.000 190.875
2022-04-15 2022-04-13 4 Renger John CERE Common Stock S - Sale D 34,6465 -45.000 -1.559 1.980
2022-04-15 2022-04-13 4 Renger John CERE Common Stock M - Exercise D 3,5000 45.000 158 46.980
2022-04-04 2022-03-31 4 PF Equity Holdings 1 B.V. CERE Common Stock J - Other D -27.349.211 0
2022-03-31 2022-03-29 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -10.000 235.875
2022-03-31 2022-03-29 4 Renger John CERE Common Stock S - Sale D 35,0000 -10.000 -350 1.980
2022-03-31 2022-03-29 4 Renger John CERE Common Stock M - Exercise D 3,5000 10.000 35 11.980
2022-03-18 2022-03-18 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -20.000 245.875
2022-03-18 2022-03-18 4 Renger John CERE Common Stock S - Sale D 32,5002 -20.000 -650 1.980
2022-03-18 2022-03-18 4 Renger John CERE Common Stock M - Exercise D 3,5000 20.000 70 21.980
2022-03-18 2022-03-16 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -25.000 265.875
2022-03-18 2022-03-16 4 Renger John CERE Common Stock S - Sale D 30,0002 -25.000 -750 1.980
2022-03-18 2022-03-16 4 Renger John CERE Common Stock M - Exercise D 3,5000 25.000 88 26.980
2022-03-11 2022-03-09 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -30.000 290.875
2022-03-11 2022-03-09 4 Renger John CERE Common Stock S - Sale D 35,0000 -10.000 -350 1.980
2022-03-11 2022-03-09 4 Renger John CERE Common Stock S - Sale D 32,5000 -20.000 -650 11.980
2022-03-11 2022-03-09 4 Renger John CERE Common Stock M - Exercise D 3,5000 30.000 105 31.980
2022-03-04 2022-03-02 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -25.000 320.875
2022-03-04 2022-03-02 4 Renger John CERE Common Stock S - Sale D 30,0000 -25.000 -750 1.980
2022-03-04 2022-03-02 4 Renger John CERE Common Stock M - Exercise D 3,5000 25.000 88 26.980
2022-02-11 2022-02-09 4 Bodenrader Mark CERE Stock Option (Right to Buy) A - Award D 30,36 24.800 24.800
2022-02-11 2022-02-09 4 COLES N ANTHONY CERE Stock Option (Right to Buy) A - Award D 30,36 425.772 425.772
2022-02-11 2022-02-09 4 Ceesay Abraham CERE Stock Option (Right to Buy) A - Award D 30,36 120.310 120.310
2022-02-11 2022-02-09 4 Renger John CERE Stock Option (Right to Buy) A - Award D 30,36 168.856 168.856
2022-02-11 2022-02-09 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -25.000 345.875
2022-02-11 2022-02-09 4 Renger John CERE Common Stock S - Sale D 30,0000 -25.000 -750 1.980
2022-02-11 2022-02-09 4 Renger John CERE Common Stock M - Exercise D 3,5000 25.000 88 26.980
2022-02-11 2022-02-09 4 Sanchez Ramiro CERE Stock Option (Right to Buy) A - Award D 30,36 168.856 168.856
2022-02-11 2022-02-09 4 Akamine Scott CERE Stock Option (Right to Buy) A - Award D 30,36 58.572 58.572
2022-02-11 2022-02-09 4 DiPietro Kenneth CERE Stock Option (Right to Buy) A - Award D 30,36 75.985 75.985
2022-02-11 2022-02-09 4 Tregoning Kathleen CERE Stock Option (Right to Buy) A - Award D 30,36 63.321 63.321
2022-01-06 2022-01-04 4 RIEDEL NORBERT G CERE Restricted Stock Units M - Exercise D -14.270 0
2022-01-06 2022-01-04 4 RIEDEL NORBERT G CERE Common Stock M - Exercise D 14.270 42.810
2021-12-28 2021-12-27 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -4.127 370.875
2021-12-28 2021-12-27 4 Renger John CERE Common Stock S - Sale D 35,0000 -4.127 -144 1.980
2021-12-28 2021-12-27 4 Renger John CERE Common Stock M - Exercise D 3,5000 4.127 14 6.107
2021-12-28 2021-12-23 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -5.873 375.002
2021-12-28 2021-12-23 4 Renger John CERE Common Stock S - Sale D 35,0046 -5.873 -206 1.980
2021-12-28 2021-12-23 4 Renger John CERE Common Stock M - Exercise D 3,5000 5.873 21 7.853
2021-12-23 2021-12-21 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -7.300 380.875
2021-12-23 2021-12-21 4 Renger John CERE Common Stock S - Sale D 32,5000 -7.300 -237 1.980
2021-12-23 2021-12-21 4 Renger John CERE Common Stock M - Exercise D 3,5000 7.300 26 9.280
2021-12-17 2021-12-17 4 Renger John CERE Common Stock S - Sale D 32,5000 -7.122 -231 1.980
2021-12-17 2021-12-17 4 Renger John CERE Common Stock M - Exercise D 3,5000 7.122 25 9.102
2021-12-17 2021-12-16 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -5.578 395.297
2021-12-17 2021-12-16 4 Renger John CERE Common Stock S - Sale D 32,5000 -5.578 -181 1.980
2021-12-17 2021-12-16 4 Renger John CERE Common Stock M - Exercise D 3,5000 5.578 20 7.558
2021-12-17 2021-12-15 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -25.000 400.875
2021-12-17 2021-12-15 4 Renger John CERE Common Stock S - Sale D 30,0179 -25.000 -750 1.980
2021-12-17 2021-12-15 4 Renger John CERE Common Stock M - Exercise D 3,5000 25.000 88 26.980
2021-12-17 2017-12-17 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -7.122 388.175
2021-11-15 2021-11-10 4 Renger John CERE Stock Option (Right to Buy) M - Exercise D 3,50 -55.000 425.875
2021-11-15 2021-11-10 4 Renger John CERE Common Stock S - Sale D 42,3746 -2.063 -87 0
2021-11-15 2021-11-10 4 Renger John CERE Common Stock S - Sale D 41,4372 -13.140 -544 2.063
2021-11-15 2021-11-10 4 Renger John CERE Common Stock S - Sale D 40,4123 -10.030 -405 15.203
2021-11-15 2021-11-10 4 Renger John CERE Common Stock S - Sale D 39,6094 -6.135 -243 25.233
2021-11-15 2021-11-10 4 Renger John CERE Common Stock S - Sale D 38,5894 -23.632 -912 31.368
2021-11-15 2021-11-10 4 Renger John CERE Common Stock M - Exercise D 3,5000 55.000 192 55.000
2021-09-28 2021-09-24 4 DEKKERS MARIJN E CERE Restricted Stock Units M - Exercise D -14.270 0
2021-09-28 2021-09-24 4 DEKKERS MARIJN E CERE Common Stock M - Exercise D 14.270 42.810
2021-09-20 3 PF Equity Holdings 1 B.V. CERE Common Stock D 27.349.211
2021-08-31 2021-08-26 4 PERCEPTIVE ADVISORS LLC CERE Common Stock P - Purchase I 30,2300 68.047 2.057 5.086.727
2021-08-25 2021-08-25 4 PERCEPTIVE ADVISORS LLC CERE Common Stock P - Purchase I 28,5700 61.387 1.754 5.018.680
2021-08-25 2021-08-24 4 PERCEPTIVE ADVISORS LLC CERE Common Stock P - Purchase I 27,7300 69.761 1.934 4.957.293
2021-08-25 2021-08-23 4 PERCEPTIVE ADVISORS LLC CERE Common Stock P - Purchase I 25,7800 44.437 1.146 4.887.532
2021-07-09 2021-07-07 4 PERCEPTIVE ADVISORS LLC CERE Common Stock P - Purchase I 25,0000 200.000 5.000 4.843.095
2021-06-24 2021-06-24 4 Greene-Sulzberger Gabrielle CERE Restricted Stock Units M - Exercise D -14.270 14.270
2021-06-24 2021-06-24 4 Greene-Sulzberger Gabrielle CERE Common Stock M - Exercise D 14.270 49.624
2021-06-22 2021-06-17 4 Greene-Sulzberger Gabrielle CERE Common Stock P - Purchase D 13,0600 21.084 275 35.354
2021-06-14 2021-06-10 4 Gordon Christopher R CERE Stock Option (Right to Buy) A - Award D 13,93 42.950 42.950
2021-06-14 2021-06-10 4 Koppel Adam CERE Stock Option (Right to Buy) A - Award D 13,93 42.950 42.950
2021-06-14 2021-06-10 4 RIEDEL NORBERT G CERE Stock Option (Right to Buy) A - Award D 13,93 58.003 58.003
2021-06-14 2021-06-10 4 Greene-Sulzberger Gabrielle CERE Stock Option (Right to Buy) A - Award D 13,93 58.003 58.003
2021-06-14 2021-06-10 4 DEKKERS MARIJN E CERE Stock Option (Right to Buy) A - Award D 13,93 58.003 58.003
2021-06-14 2021-06-10 4 Giordano Douglas E. CERE Stock Option (Right to Buy) A - Award D 13,93 58.003 58.003
2021-06-03 2021-06-01 4 Akamine Scott CERE Stock Option (Right to Buy) A - Award D 13,17 281.762 281.762
2021-06-03 2021-06-01 4 Ceesay Abraham CERE Stock Option (Right to Buy) A - Award D 13,17 461.065 461.065
2021-02-05 2021-02-03 4 Sanchez Ramiro CERE Stock Option (Right to Buy) A - Award D 12,70 278.637 278.637
2021-02-05 2021-02-03 4 Renger John CERE Stock Option (Right to Buy) A - Award D 12,70 247.678 247.678
2021-02-05 2021-02-03 4 Tregoning Kathleen CERE Stock Option (Right to Buy) A - Award D 12,70 77.399 77.399
2021-02-05 2021-02-03 4 COLES N ANTHONY CERE Stock Option (Right to Buy) A - Award D 12,70 732.714 732.714
2021-02-05 2021-02-03 4 DiPietro Kenneth CERE Stock Option (Right to Buy) A - Award D 12,70 175.438 175.438
2021-02-05 2021-02-03 4 Bodenrader Mark CERE Stock Option (Right to Buy) A - Award D 12,70 90.000 90.000
2021-02-05 2021-02-03 4 Yi Kathy CERE Stock Option (Right to Buy) A - Award D 12,70 216.718 216.718
2021-02-03 2021-02-01 4 PATRICK DEVAL L CERE Stock Option (Right to Buy) A - Award D 12,62 90.390 90.390
2021-02-03 2021-02-01 4 Baron Deborah CERE Stock Option (Right to Buy) A - Award D 12,62 90.390 90.390
2021-01-28 2021-01-26 4 MISHAN ORLY CERE Stock Option (Right to Buy) M - Exercise D 3,50 -38.450 426.913
2021-01-28 2021-01-26 4 MISHAN ORLY CERE Common Stock M - Exercise D 3,5000 38.450 135 38.450
2021-01-11 2021-01-04 4 Mckernan Ruth CERE Stock Option (Right to Buy) A - Award D 16,41 80.945 80.945
2021-01-06 2021-01-04 4 RIEDEL NORBERT G CERE Restricted Stock Units M - Exercise D -14.270 14.270
2021-01-06 2021-01-04 4 RIEDEL NORBERT G CERE Common Stock M - Exercise D 14.270 28.540
2020-12-08 2020-12-04 4 Tregoning Kathleen CERE Stock Option (Right to Buy) A - Award D 15,45 78.229 78.229
2020-11-12 2020-11-09 4 Koppel Adam CERE Common Stock P - Purchase I 10,3000 332.293 3.423 60.632.356
2020-11-12 2020-11-09 4 BAIN CAPITAL INVESTORS LLC CERE Common Stock P - Purchase I 10,3000 332.293 3.423 60.632.356
2020-11-12 2020-11-09 4 Gordon Christopher R CERE Common Stock P - Purchase I 10,3000 332.293 3.423 60.632.356
2020-10-30 2020-10-28 4 Yi Kathy CERE Stock Option (Right to Buy) A - Award D 9,88 78.534 78.534
2020-10-30 2020-10-28 4 Sanchez Ramiro CERE Stock Option (Right to Buy) A - Award D 9,88 130.890 130.890
2020-10-30 2020-10-28 4 COLES N ANTHONY CERE Stock Option (Right to Buy) A - Award D 9,88 196.335 196.335
2020-10-30 2020-10-28 4 Bodenrader Mark CERE Stock Option (Right to Buy) A - Award D 9,88 65.445 65.445
2020-10-30 2020-10-28 4 Renger John CERE Stock Option (Right to Buy) A - Award D 9,88 117.801 117.801
2020-10-30 3 DEKKERS MARIJN E CERE Common Stock D 28.540
2020-10-30 3 DiPietro Kenneth CERE Common Stock D 14.270
2020-10-30 3 RIEDEL NORBERT G CERE Common Stock D 14.270
2020-10-30 3 Greene-Sulzberger Gabrielle CERE Common Stock D 14.270
2020-10-29 2020-10-27 4 Gordon Christopher R See Footnotes CERE Common Stock P - Purchase I 10,0000 10.000.000 100.000 60.300.063
2020-10-29 2020-10-27 4 Gordon Christopher R See Footnotes CERE Common Stock J - Other I 49.961.943 50.300.063
2020-10-29 2020-10-27 4 Koppel Adam See Footnotes CERE Common Stock P - Purchase I 10,0000 10.000.000 100.000 60.300.063
2020-10-29 2020-10-27 4 Koppel Adam See Footnotes CERE Common Stock J - Other I 49.961.943 50.300.063
2020-10-29 2020-10-27 4 PERCEPTIVE ADVISORS LLC CERE Common stock P - Purchase I 10,0000 3.000.000 30.000 3.157.295
2020-10-29 2020-10-27 4 BAIN CAPITAL INVESTORS LLC See Footnotes CERE Common Stock P - Purchase I 10,0000 10.000.000 100.000 60.300.063
2020-10-29 3 Bain Capital Partners XII, LLC See footnotes CERE Common Stock I 50.300.063
2020-10-29 3 Koppel Adam See footnotes CERE Common Stock I 338.120
2020-10-29 3 Gordon Christopher R See footnotes CERE Common Stock I 338.120
2020-10-29 2020-10-27 4 PFIZER INC CERF Common Stock P - Purchase D 10,0000 1.200.000 12.000 27.349.211
2020-10-29 3 PFIZER INC CERF Common Stock D 26.149.211
2020-10-22 2020-10-21 4 PERCEPTIVE ADVISORS LLC ARYB Class A ordinary shares P - Purchase I 10,0900 43.195 436 157.295
2020-10-22 2020-10-20 4 PERCEPTIVE ADVISORS LLC ARYB Class A ordinary shares P - Purchase I 10,0000 114.100 1.141 114.100
2020-06-09 2020-06-09 4 Stone Adam Leo By ARYA Sciences Holdings II ARYB Class A ordinary shares J - Other I 10,0000 499.000 4.990 499.000
2020-06-09 2020-06-09 4 ARYA Sciences Holdings II ARYB Class A ordinary shares J - Other D 10,0000 499.000 4.990 499.000
2020-06-09 2020-06-09 4 ALTMAN MICHAEL SETH By ARYA Sciences Holdings II ARYB Class A ordinary shares J - Other I 10,0000 499.000 4.990 499.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista